How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population
Identifieur interne : 004A59 ( Main/Exploration ); précédent : 004A58; suivant : 004A60How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population
Auteurs : Anette Schrag [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Niall Quinn [Royaume-Uni]Source :
- Movement Disorders [ 0885-3185 ] ; 2000-11.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme, Qualité de la vie.
English descriptors
- KwdEn :
- Adult, Age Factors, Aged, Aged, 80 and over, Clinical stage, Comparative study, Cost of Illness, Cross-Sectional Studies, Evaluation, Female, Great Britain (epidemiology), Health Status, Health state, Human, Humans, Male, Middle Aged, Neurologic Examination, Pain (psychology), Parkinson Disease (epidemiology), Parkinson Disease (psychology), Parkinson disease, Parkinson's disease, Population Surveillance, Population‐based, Prevalence, Psychometrics, Quality of Life, Quality of life, Questionnaires, Severity of Illness Index, Social Adjustment, Social Support.
- MESH :
- geographic , epidemiology : Great Britain.
- epidemiology : Parkinson Disease.
- psychology : Pain, Parkinson Disease.
- Adult, Age Factors, Aged, Aged, 80 and over, Cost of Illness, Cross-Sectional Studies, Female, Health Status, Humans, Male, Middle Aged, Neurologic Examination, Population Surveillance, Prevalence, Quality of Life, Questionnaires, Severity of Illness Index, Social Adjustment, Social Support.
Abstract
BACKGROUND: Adequate provision of appropriate healthcare resources for patients with chronic neurologic disorders such as Parkinson's disease (PD) requires knowledge of the impact of the illness on their life. Quality of life (QoL) instruments measure the impact of the disease on general well‐being that cannot be fully appreciated by clinical rating scales and allow comparisons with other patient groups and the general population. OBJECTIVES: To assess QoL in a population‐based sample of patients with PD in different disease stages in comparison with the general population. METHODS: All 124 patients with PD seen in a population‐based study on the prevalence of parkinsonism in the London area were asked to complete a QoL battery including the EuroQoL 5D (EQ‐5D), the Medical Outcome Study Short Form (SF 36), and the 39‐item Parkinson's Disease questionnaire (PDQ‐39). An interview and complete neurologic examination, including the Hoehn and Yahr scale, were performed on the same day. The patients' QoL scores were compared with published QoL norms from the United Kingdom population. RESULTS: Quality of life, as measured by the PDQ‐39, the EQ‐5D, and the physical summary of the SF 36, deteriorated significantly with increasing disease severity. The greatest impairment was seen in the areas related to physical and social functioning, whereas reports of pain and poor emotional adjustment had similar prevalence in patients with PD and the general population. The impairment of QoL was seen in all age groups and was similar for men and women, but the differences between patients with PD and the general population were most marked in the younger patient groups. CONCLUSIONS: Parkinson's disease interferes with various aspects of QoL, particularly those related to physical and social functioning. This information should be taken into account in the clinical management and planning and allocation of healthcare resources to this population.
Url:
DOI: 10.1002/1531-8257(200011)15:6<1112::AID-MDS1008>3.0.CO;2-A
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000A92
- to stream Istex, to step Curation: 000A92
- to stream Istex, to step Checkpoint: 003259
- to stream Main, to step Merge: 007356
- to stream PascalFrancis, to step Corpus: 002A96
- to stream PascalFrancis, to step Curation: 000225
- to stream PascalFrancis, to step Checkpoint: 002B96
- to stream Main, to step Merge: 007588
- to stream PubMed, to step Corpus: 003E72
- to stream PubMed, to step Curation: 003E72
- to stream PubMed, to step Checkpoint: 003F72
- to stream Ncbi, to step Merge: 000379
- to stream Ncbi, to step Curation: 000379
- to stream Ncbi, to step Checkpoint: 000379
- to stream Main, to step Merge: 007115
- to stream Main, to step Curation: 004A59
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population</title>
<author><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name>
</author>
<author><name sortKey="Jahanshahi, Marjan" sort="Jahanshahi, Marjan" uniqKey="Jahanshahi M" first="Marjan" last="Jahanshahi">Marjan Jahanshahi</name>
</author>
<author><name sortKey="Quinn, Niall" sort="Quinn, Niall" uniqKey="Quinn N" first="Niall" last="Quinn">Niall Quinn</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:90EBFA3A3838C35DE8A83B2F7F02A56B4855C1F6</idno>
<date when="2000" year="2000">2000</date>
<idno type="doi">10.1002/1531-8257(200011)15:6<1112::AID-MDS1008>3.0.CO;2-A</idno>
<idno type="url">https://api.istex.fr/document/90EBFA3A3838C35DE8A83B2F7F02A56B4855C1F6/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000A92</idno>
<idno type="wicri:Area/Istex/Curation">000A92</idno>
<idno type="wicri:Area/Istex/Checkpoint">003259</idno>
<idno type="wicri:doubleKey">0885-3185:2000:Schrag A:how:does:parkinson</idno>
<idno type="wicri:Area/Main/Merge">007356</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:01-0016728</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002A96</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000225</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002B96</idno>
<idno type="wicri:doubleKey">0885-3185:2000:Schrag A:how:does:parkinson</idno>
<idno type="wicri:Area/Main/Merge">007588</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:11104193</idno>
<idno type="wicri:Area/PubMed/Corpus">003E72</idno>
<idno type="wicri:Area/PubMed/Curation">003E72</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003F72</idno>
<idno type="wicri:Area/Ncbi/Merge">000379</idno>
<idno type="wicri:Area/Ncbi/Curation">000379</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000379</idno>
<idno type="wicri:doubleKey">0885-3185:2000:Schrag A:how:does:parkinson</idno>
<idno type="wicri:Area/Main/Merge">007115</idno>
<idno type="wicri:Area/Main/Curation">004A59</idno>
<idno type="wicri:Area/Main/Exploration">004A59</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population</title>
<author><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jahanshahi, Marjan" sort="Jahanshahi, Marjan" uniqKey="Jahanshahi M" first="Marjan" last="Jahanshahi">Marjan Jahanshahi</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Quinn, Niall" sort="Quinn, Niall" uniqKey="Quinn N" first="Niall" last="Quinn">Niall Quinn</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>John Wiley & Sons, Inc.</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2000-11">2000-11</date>
<biblScope unit="vol">15</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="1112">1112</biblScope>
<biblScope unit="page" to="1118">1118</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">90EBFA3A3838C35DE8A83B2F7F02A56B4855C1F6</idno>
<idno type="DOI">10.1002/1531-8257(200011)15:6<1112::AID-MDS1008>3.0.CO;2-A</idno>
<idno type="ArticleID">MDS1008</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Clinical stage</term>
<term>Comparative study</term>
<term>Cost of Illness</term>
<term>Cross-Sectional Studies</term>
<term>Evaluation</term>
<term>Female</term>
<term>Great Britain (epidemiology)</term>
<term>Health Status</term>
<term>Health state</term>
<term>Human</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neurologic Examination</term>
<term>Pain (psychology)</term>
<term>Parkinson Disease (epidemiology)</term>
<term>Parkinson Disease (psychology)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Population Surveillance</term>
<term>Population‐based</term>
<term>Prevalence</term>
<term>Psychometrics</term>
<term>Quality of Life</term>
<term>Quality of life</term>
<term>Questionnaires</term>
<term>Severity of Illness Index</term>
<term>Social Adjustment</term>
<term>Social Support</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Great Britain</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Pain</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Cost of Illness</term>
<term>Cross-Sectional Studies</term>
<term>Female</term>
<term>Health Status</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neurologic Examination</term>
<term>Population Surveillance</term>
<term>Prevalence</term>
<term>Quality of Life</term>
<term>Questionnaires</term>
<term>Severity of Illness Index</term>
<term>Social Adjustment</term>
<term>Social Support</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Etude comparative</term>
<term>Evaluation</term>
<term>Homme</term>
<term>Parkinson maladie</term>
<term>Psychométrie</term>
<term>Qualité vie</term>
<term>Stade clinique</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
<term>Qualité de la vie</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">BACKGROUND: Adequate provision of appropriate healthcare resources for patients with chronic neurologic disorders such as Parkinson's disease (PD) requires knowledge of the impact of the illness on their life. Quality of life (QoL) instruments measure the impact of the disease on general well‐being that cannot be fully appreciated by clinical rating scales and allow comparisons with other patient groups and the general population. OBJECTIVES: To assess QoL in a population‐based sample of patients with PD in different disease stages in comparison with the general population. METHODS: All 124 patients with PD seen in a population‐based study on the prevalence of parkinsonism in the London area were asked to complete a QoL battery including the EuroQoL 5D (EQ‐5D), the Medical Outcome Study Short Form (SF 36), and the 39‐item Parkinson's Disease questionnaire (PDQ‐39). An interview and complete neurologic examination, including the Hoehn and Yahr scale, were performed on the same day. The patients' QoL scores were compared with published QoL norms from the United Kingdom population. RESULTS: Quality of life, as measured by the PDQ‐39, the EQ‐5D, and the physical summary of the SF 36, deteriorated significantly with increasing disease severity. The greatest impairment was seen in the areas related to physical and social functioning, whereas reports of pain and poor emotional adjustment had similar prevalence in patients with PD and the general population. The impairment of QoL was seen in all age groups and was similar for men and women, but the differences between patients with PD and the general population were most marked in the younger patient groups. CONCLUSIONS: Parkinson's disease interferes with various aspects of QoL, particularly those related to physical and social functioning. This information should be taken into account in the clinical management and planning and allocation of healthcare resources to this population.</div>
</front>
</TEI>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement><li>Londres</li>
</settlement>
</list>
<tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name>
</region>
<name sortKey="Jahanshahi, Marjan" sort="Jahanshahi, Marjan" uniqKey="Jahanshahi M" first="Marjan" last="Jahanshahi">Marjan Jahanshahi</name>
<name sortKey="Quinn, Niall" sort="Quinn, Niall" uniqKey="Quinn N" first="Niall" last="Quinn">Niall Quinn</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004A59 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004A59 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:90EBFA3A3838C35DE8A83B2F7F02A56B4855C1F6 |texte= How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population }}
This area was generated with Dilib version V0.6.23. |